NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

C-3002: Enhancing Cervical Cancer Screening Access and Follow-up Care at 'CASCADE' Clinical Sites in the United States

NCT07520188

Not Yet RecruitingN/A

Sponsor: UNC Lineberger Comprehensive Cancer Center

Conditions: Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV), Cervical Cancer, Cervical Precancer

Interventions: Qualitative interviews, Focus groups

Countries: United States

The purpose of the CASCADE-3002 project is to improve access to cervical cancer screening among women with Human Immunodeficiency Virus (HIV) receiving care at U.S.-based CASCADE clinical sites. This study will assess the cervical cancer screening cascade and identify multilevel factors that impede access to screening among women with HIV attending Infectious Disease clinics in Georgia and Maryland. In parallel, the study will explore and develop implementation strategies for human papillomavirus (HPV) self-collection to increase screening uptake, adherence, and appropriate clinical follow-up in this population at elevated risk for cervical cancer. Cervical cancer remains a preventable malignancy; however, women with HIV are at substantially increased risk and experience higher rates of cervical cancer compared with women without HIV. The World Health Organization has called for the global elimination of cervical cancer as a public health problem, defined as fewer than 4 incident cases per 100,000 women annually, with targets for vaccination, screening, and treatment coverage. Although the United States has the tools to approach near-elimination, disparities in healthcare access and screening persist, particularly among women with HIV.

Eligibility overview

Sex: ALL

Age: 25 Years to 49 Years

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Aim 1b Inclusion Criteria

* women with Human Immunodeficiency Virus (HIV) receive care
* ages between 25- 49
* eligible for cervical cancer screening per national US guidelines

Aim 1b Exclusion Criteria • Women without an intact cervix.

Aim 2 Inclusion Criteria:

* Clinical team members who work and provide care to women living with HIV at three clinical locations: the Center for Infectious Diseases (CID) at the University of Maryland School of Medicine in Baltimore, MD; Ponce de Leon Clinic at Emory University in Atlanta, GA; and Albany Area Primary Health Care in Albany, GA. a
* Clinical team members will include: providers (Physicians, Nurse practitioners, Physician's Assistants, Nurses, Nursing Assistants, Medical Assistants, Pharmacists), laboratory members, or other staff involved in clinic operations.

Aim 2 Exclusion Criteria

• Individuals who do not work for the Center for Infectious Diseases (CID) at the University of Maryland School of Medicine in Baltimore, MD or the Ponce de Leon Clinic at Emory University in Atlanta, GA

Locations (2)

Atlanta, Georgia, United States
Baltimore, Maryland, United States